USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Artificial Intelligence Powering the Global Medical Imaging Market
Artificial Intelligence Powering the Global Medical Imaging Market
Efficiency Tools and Workflow Optimization to Drive Future Growth Potential
RELEASE DATE
27-Jan-2021
27-Jan-2021
REGION
North America
North America
Research Code: K546-01-00-00-00
SKU: HC03387-NA-TC_25209
$7,500.00
Special Price $6,750.00 save 10 %
In stock
SKU
HC03387-NA-TC_25209
Description
The medical imaging and informatics industry is evolving, with vendors launching new products and solutions every other day. As the reimbursement environment transitions from fee-for-service to value-based payment, vendors’ business models and value propositions are changing. New evidence on the use of specific imaging techniques is influencing changes in the care standard. On a macro level, government policies on reimbursement and regulations tend to impact industry participants' performance if their internal teams delay the strategic actions needed to thrive in this new environment.
Frost & Sullivan has introduced the medical imaging and informatics industry semi-annual insights tracker to help clients address challenges in a competitive environment. Covering the diagnostic imaging, image-guided therapies, and imaging informatics segments, the tracker will monitor market factors and significant events and qualitatively assess their industry impact.
Research Highlights
Clinical Trends:
- Disruptive trends impacting the current gold standard
- Trends indicating the clinical adoption of new solutions/products
- Essential announcements from associations, such as the Radiological Society of North America (RSNA), European Society of Radiology (ESR), American College of Radiology (ACR), and American College of Cardiology (ACC)
Competition:
- New product launches and capabilities
- Mergers and acquisitions
- United States Food and Drug Administration (USFDA) and Conformité Européenne (CE) approvals
- Prominent FDA and CE recalls/warnings
Policies and Regulations:
- Introduction of region-specific regulatory approvals
- Reimbursement achievements or setbacks
Event Highlights:
- Major events highlights, covering significant themes derived by studying the messaging and communications, product launches, and product promotions at the event
Author: Suresh Kuppuswamy
Table of Contents
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Global Medical Imaging and Informatics Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Medical Imaging and Informatics Industry Scope of Analysis
Study Indicators—Medical Imaging and Informatics Industry
Executive Summary—Medical Imaging and Informatics Industry
Long-Term Contracts (Customer Acquisitions)—Medical Imaging and Informatics Industry
Long-Term Contracts (Customer Acquisitions)—Medical Imaging and Informatics Industry (continued)
New Launches and Upgrades—Medical Imaging and Informatics Industry
New Launches and Upgrades—Medical Imaging and Informatics Industry (continued)
New Launches and Upgrades—Medical Imaging and Informatics Industry (continued)
New Launches and Upgrades—Medical Imaging and Informatics Industry (continued)
New Launches and Upgrades—Medical Imaging and Informatics Industry (continued)
Mergers and Acquisitions—Medical Imaging and Informatics Industry
Mergers and Acquisitions—Medical Imaging and Informatics Industry (continued)
Mergers and Acquisitions—Medical Imaging and Informatics Industry (continued)
Strategic Partnerships—Medical Imaging and Informatics Industry
Strategic Partnerships—Medical Imaging and Informatics Industry (continued)
Strategic Partnerships—Medical Imaging and Informatics Industry (continued)
Strategic Partnerships—Medical Imaging and Informatics Industry (continued)
USFDA Approvals (MRI)—Medical Imaging and Informatics Industry
USFDA Approvals (CT)—Medical Imaging and Informatics Industry
USFDA Approvals (Ultrasound)—Medical Imaging and Informatics Industry
USFDA Approvals (Ultrasound)—Medical Imaging and Informatics Industry (continued)
USFDA Approvals (Molecular Imaging)—Medical Imaging and Informatics Industry
USFDA Approvals (Fluoroscopy)—Medical Imaging and Informatics Industry
USFDA Approvals (X-Ray)—Medical Imaging and Informatics Industry
USFDA Approvals (X-Ray)—Medical Imaging and Informatics Industry (continued)
USFDA Approvals (Breast Imaging)—Medical Imaging and Informatics Industry
USFDA Approvals (Therapy)—Medical Imaging and Informatics Industry
USFDA Approvals (Software)—Medical Imaging and Informatics Industry
USFDA Approvals (Software)—Medical Imaging and Informatics Industry (continued)
USFDA Approvals (Software)—Medical Imaging and Informatics Industry (continued)
USFDA Approvals (Software)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry
USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
Clinical Trends—Medical Imaging and Informatics Industry
Clinical Trends—Medical Imaging and Informatics Industry (continued)
Clinical Trends—Medical Imaging and Informatics Industry (continued)
Clinical Trends—Medical Imaging and Informatics Industry (continued)
Clinical Trends—Medical Imaging and Informatics Industry (continued)
Clinical Trends—Medical Imaging and Informatics Industry (continued)
Clinical Trends—Medical Imaging and Informatics Industry (continued)
Policies and Regulations (US)—Medical Imaging and Informatics Industry
Policies and Regulations (US)—Medical Imaging and Informatics Industry (continued)
Policies and Regulations (US)—Medical Imaging and Informatics Industry (continued)
Policies and Regulations (Australia)—Medical Imaging and Informatics Industry
Policies and Regulations (Europe)—Medical Imaging and Informatics Industry
Trending Themes at HIMSS 2020—Medical Imaging and Informatics Industry
Vendor Highlights at HIMSS 2020—Medical Imaging and Informatics Industry
Vendor Highlights at HIMSS 2020—Medical Imaging and Informatics Industry (continued)
Vendor Highlights at American College of Cardiology 2020—Medical Imaging and Informatics Industry
Your Next Steps
Why Frost, Why Now?
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
Related Research
Popular Topics
The medical imaging and informatics industry is evolving, with vendors launching new products and solutions every other day. As the reimbursement environment transitions from fee-for-service to value-based payment, vendors business models and value propositions are changing. New evidence on the use of specific imaging techniques is influencing changes in the care standard. On a macro level, government policies on reimbursement and regulations tend to impact industry participants' performance if their internal teams delay the strategic actions needed to thrive in this new environment.
Frost & Sullivan has introduced the medical imaging and informatics industry semi-annual insights tracker to help clients address challenges in a competitive environment. Covering the diagnostic imaging, image-guided therapies, and imaging informatics segments, the tracker will monitor market factors and significant events and qualitatively assess their industry impact.--BEGIN PROMO--
Research Highlights
Clinical Trends:
- Disruptive trends impacting the current gold standard
- Trends indicating the clinical adoption of new solutions/products
- Essential announcements from associations, such as the Radiological Society of North America (RSNA), European Society of Radiology (ESR), American College of Radiology (ACR), and American College of Cardiology (ACC)
Competition:
- New product launches and capabilities
- Mergers and acquisitions
- United States Food and Drug Administration (USFDA) and Conformité Européenne (CE) approvals
- Prominent FDA and CE recalls/warnings
Policies and Regulations:
- Introduction of region-specific regulatory approvals
- Reimbursement achievements or setbacks
Event Highlights:
- Major events highlights, covering significant themes derived by studying the messaging and communications, product launches, and product promotions at the event
Author: Suresh Kuppuswamy
| No Index | No |
|---|---|
| Podcast | No |
| Predecessor | MF08-01-00-00-00 |
| Author | Suresh Kuppuswamy |
| Industries | Healthcare |
| WIP Number | K546-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9566-B1,9570-B1,99BE-B1,9614-B1 |